Group B Streptococcal phage lysin
OwnerJeffrey A. Engler, Jane R. Schwebke +2inventors
InventorsJeffrey A. Engler, Jane R. Schwebke, John R. Baker, David G. Pritchard
Life of this patent
Estimating the term…
Loading patent…
OwnerJeffrey A. Engler, Jane R. Schwebke +2inventors
InventorsJeffrey A. Engler, Jane R. Schwebke, John R. Baker, David G. Pritchard
Estimating the term…
The present disclosure relates to the identification phage lysin from group B streptococci (GBS). The nucleic acid sequence and amino acid sequence of the GBS phage lysin is disclosed. The GBS phage lysin is a bifunctional protein comprising a glucosidase and an endopeptidease activity. The endopeptidase present in the GBS phage lysis has a substrate specificity that has not been previously reported. The bifunctional GBS phage lysin is effective against groups A, B, C, E and G streptococci. Also described are methods of using the GBS phage lysin for the prevention and treatment of bacterial infections.
An isolated nucleic acid comprising the nucleotide sequence of SEQ ID NO:
An isolated nucleic acid comprising a sequence that hybridizes under highly stringent conditions to a hybridization probe the nucleotide sequence of which consists of SEQ ID NO:
A purified polypeptide the amino acid sequence of which comprises SEQ ID NO:
Dependencies are inferred from the claim text.